Phase one of clinical trials on the first group of 44 children from 3 to 11 years of age with the Cuban vaccine Abdala raises expectations among the population in this eastern province.
When COVID-19 emerged, the disease was interpreted as a serious respiratory viral infection and, in the first months, the attention of specialists was focused on that aspect, but with the increase of cases and its expansion, it was seen that it was a multisystemic disease, with generalized repercussions in the organism and sequels.
As of July 27, the Cuban ministry of public health (MINSAP by its Spanish acronym) reported today that 9,085,122 doses of the Cuban anti-COVID-19 vaccine candidates have been administered. According to MINSAP, to date 3,500,505 people have received at least one dose of one of the Cuban vaccine candidates; of these, 3,48,468 people have already received a second dose and 2,536,149 have received a third one.
The vaccination against COVID-19 to the population over 19 years of age, which will be extended from tomorrow to the seven municipalities of Matanzas(western province) that have not yet started the immunization, will have the support of more than 400 private drivers, said Roberto Bernal Villena, provincial director of the sector.